Amgen Inc. (AMGN) Total liabilities 2016–2025
Amgen Inc. (AMGN) total liabilities at each fiscal year-end, per SEC filings.
$81.9BFY2025 · since FY2016: $47.8B → $81.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $81.9B | -4.7% |
| FY2024 | $86.0B | -5.5% |
| FY2023 | $90.9B | +47.9% |
| FY2022 | $61.5B | +12.8% |
| FY2021 | $54.5B | +1.7% |
| FY2020 | $53.5B | +7.0% |
| FY2019 | $50.0B | -7.2% |
| FY2018 | $53.9B | -1.5% |
| FY2017 | $54.7B | +14.6% |
| FY2016 | $47.8B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice